Amylyx Pharmaceuticals (AMLX) Return on Capital Employed Growth (3y) (2025 - 2026)
Amylyx Pharmaceuticals (AMLX) Return on Capital Employed Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.35 Bn | 4.35 Bn | - | -4,072.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,072.00 |
| Mar 31, 2026 | -890.00 |
| Dec 31, 2025 | 3,678.00 |
| Sep 30, 2025 | 4,620.00 |
| Jun 30, 2025 | -3,722.00 |
| Mar 31, 2025 | -4,962.00 |